retatrutide safety retatrutide clinical trial ESC 2024: improves lipid and cardiovascular risk profile in Phase II RETATRUTIDE (RETA) – Research Peptide

Clinical trials have shown retatrutide can lead to significant weight reduction and better blood sugar control

FAQ 4: Are certain GLP-1 medications more likely to cause hair loss than others

So I tried a few things I had in my toolbox to get a bit more space to better see the play

[1] It is important to note that weight loss was smaller in participants with type 2 diabetes, consistent with findings seen with other agents in this class

Common adverse effects of Ozempic, as documented in clinical trials and post-marketing surveillance, predominantly involve the gastrointestinal system: Vomiting Diarrhoea Constipation Abdominal pain Reduced appetite These side effects, particularly if severe or persistent, could indirectly affect sexual desire simply by making individuals feel unwell

Their salutary and what appears to be marked impact beyond losing weight is getting validated in ways not fully anticipated, affecting cardiovascular outcomes, non-alcoholic fatty liver disease, and perhaps substance and behavioral addiction